PT  - JOURNAL ARTICLE
AU  - Marc Diederichs
AU  - René Glawion
AU  - Peter G. Kremsner
AU  - Timo Mitze
AU  - Gernot J. Müller
AU  - Dominik Papies
AU  - Felix Schulz
AU  - Klaus Wälde
TI  - Is large-scale rapid CoV-2 testing a substitute for lockdowns?
AID  - 10.1101/2021.04.26.21256094
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.04.26.21256094
4099  - http://medrxiv.org/content/early/2021/08/06/2021.04.26.21256094.short
4100  - http://medrxiv.org/content/early/2021/08/06/2021.04.26.21256094.full
AB  - BACKGROUND Various forms of contact restrictions have been adopted in response to the Covid-19 pandemic. Around February 2021, rapid testing appeared as a new policy instrument. Some claim it may serve as a substitute for contact restrictions.OBJECTIVES/METHODS We evaluate the effects of a unique policy experiment: In March and April 2021, the city of Tübingen set up a testing scheme while relaxing contact restrictions. We compare case rates in Tübingen county to an appropriately identified control unit.CONCLUSIONS The experiment led to an increase in the reported case rate. This increase is robust across alternative statistical specifications. An epidemiological model that corrects for ‘more cases due to more testing’ and ‘reduced testing and reporting during the Easter holiday’ also confirms the finding.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno external funding Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:not requiredAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesall data is public